TEMOZOLAMIDE 180 Pill — BROWN;WHITE CAPSULE, 22mm — Temozolomide

No photo available

Imprint	TEMOZOLAMIDE / 180
Colour	BROWN;WHITE
Shape	CAPSULE
Size	22
Strength	Temozolomide 180 mg
Dosage form	Capsule
Manufacturer	IDT Australia Limited
NDC	64144-505
Schedule	—
Availability	—
Ingredients	Temozolomide[Temozolomide]

What does this imprint mean?

The imprint "TEMOZOLAMIDE 180" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Temozolomide

Uses and warnings

BOXED WARNING: Myelosuppression - "Myelosuppression, including pancytopenia, leukopenia...and anemia, some with fatal outcomes, have occurred," with approximately 10% of patients requiring hospitalization or transfusion; blood counts must be monitored, with nadirs typically around day 26-28. Hepatotoxicity - "Fatal and severe hepatotoxicity have been reported" and liver function should be checked at baseline, mid-cycle, and after each cycle. Secondary malignancies, including myelodysplastic syndrome and secondary leukemias, have been observed. Contraindicated in patients with prior serious hypersensitivity to temozolomide or dacarbazine (shared metabolite). Also warns of Pneumocystis pneumonia risk, especially with concurrent steroid use, and embryo-fetal toxicity.

Indicated for adults with "newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment," and for "adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma" as well as "treatment of adults with refractory anaplastic astrocytoma."

Read the full drug profile →

How to identify this pill

• Check the imprint matches exactly: "TEMOZOLAMIDE 180".
• Confirm the colour (BROWN;WHITE) and shape (CAPSULE).
• Compare the size (22) against a ruler if possible.
• When in doubt, confirm with a pharmacist before taking any medication.

Similar-looking pills

OME 10

BROWN;WHITE CAPSULE · Omeprazole